Serum Glycoproteomic Alterations in Patients with Diabetic Retinopathy
The precise molecular mechanisms of diabetic retinopathy (DR) pathogenesis are unclear, and treatment options are limited. There is an urgent need to discover and develop novel therapeutic targets for the treatment of this disease. Glycosylation is a post-translational modification that plays a crit...
Main Authors: | Ashok Sharma, James Cox, Joshua Glass, Tae Jin Lee, Sai Karthik Kodeboyina, Wenbo Zhi, Lane Ulrich, Zachary Lukowski, Shruti Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Proteomes |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-7382/8/3/25 |
Similar Items
-
Integrated proteomic, phosphoproteomic, and N-glycoproteomic analyses of the longissimus thoracis of yaks
by: Xinping Chang, et al.
Published: (2022-01-01) -
Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancer
by: Daisuke Takakura, et al.
Published: (2023-02-01) -
Semi-Automated Glycoproteomic Data Analysis of LC-MS Data Using GlycopeptideGraphMS in Process Development of Monoclonal Antibody Biologics
by: Kuin Tian Pang, et al.
Published: (2021-05-01) -
Differences in aqueous humor protein profiles in patients with proliferative diabetic retinopathy before and after aflibercept treatment
by: Tan Wang, et al.
Published: (2024-01-01) -
Characterization of Cell Glycocalyx with Mass Spectrometry Methods
by: Qiongyu Li, et al.
Published: (2019-08-01)